Twenty-four-hour thallium-201 imaging enhances the detection of myocardial ischemia and viability after myocardial infarction a comparison study with echocardiography follow-up

Clinical Nuclear Medicine

Volumn 34, Issue 2, 2009, Pages 65-69

  He, Yong Ming ^a,c   Yang, Xiang Jun ^a   Wu, Yi Wei ^b   Zhang, Bin ^b  

^a Departments of Cardiology   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c NONE   (China)

Author keywords

Coronary artery disease; Echocardiography; Myocardial viability; Thallium 201

Indexed keywords

THALLIUM 201; DIAGNOSTIC AGENT; THALLIUM;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD VESSEL DIAMETER; CLINICAL ARTICLE; COLLIMATOR; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE WALL MOTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HEART SCINTISCANNING; HUMAN; IMAGE QUALITY; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; MALE; PREDICTION; SCINTILLATION CAMERA; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ULTRASOUND; COMPARATIVE STUDY; ECHOGRAPHY; INJECTION; MOVEMENT (PHYSIOLOGY); PATHOLOGY; PATHOPHYSIOLOGY; REST; SCINTISCANNING; STENOSIS, OCCLUSION AND OBSTRUCTION; TIME; TISSUE SURVIVAL;

CONSTRICTION, PATHOLOGIC; ECHOCARDIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; INJECTIONS; MOVEMENT; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL PERFUSION IMAGING; REST; THALLIUM RADIOISOTOPES; TIME FACTORS; TISSUE SURVIVAL; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 66849099488     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e318192c394     Document Type: Article

References (18)

1. Allman KC, Shaw LJ, Hachamovitch R, et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol. 2002;39:1151-1158.
2. Ohtani H, Tamaki N, Yonekura Y, et al. Value of thallium-201 reinjection after delayed SPECT imaging for predicting reversible ischemia after coronary artery bypass grafting. Am J Cardiol. 1990;66:394-399.
3. Coll C, Gonzalez P, Massardo T, et al. -Performance of Thallium 201 rest-redistribution spect to predict viability in recent myocardial infarction-. Rev Med Chil. 2002;130:243-250.
4. Matsuno K, Kuwabara Y, Watanabe S, et al. Detection of myocardial viability using rest-redistribution thallium-201 imaging in a stress 99Tcm-tetrofosmin/rest thallium-201 dual-isotope protocol. Nucl Med Commun. 2001;22:165-173.
5. Kiat H, Berman DS, Maddahi J, et al. Late reversibility of tomographic myocardial thallium-201 defects: an accurate marker of myocardial viability. J Am Coll Cardiol. 1988;12:1456-1463.
6. Wagdy HM, Christian TF, Miller TD, et al. The value of 24-hour images after rest thallium injection. Nucl Med Commun. 2002;23:629-637.
7. Matsunari I, Fujino S, Taki J, et al. Significance of late redistribution thallium-201 imaging after rest injection for detection of viable myocardium. J Nucl Med. 1997;38:1073-1078.
8. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002;105:539-542.
9. Imaging guidelines for nuclear cardiology procedures, part 2. American Society of Nuclear Cardiology. J Nucl Cardiol. 1999;6:47-84.
10. Poldermans D, Rambaldi R, Bax JJ, et al. Safety and utility of atropine addition during dobutamine stress echocardiography for the assessment of viable myocardium in patients with severe left ventricular dysfunction. Eur Heart J. 1998;19:1712-1718.
11. Klocke FJ, Baird MG, Lorell BH, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). J Am Coll Cardiol. 2003;42:1318-1333.
12. Perrone-filardi P, Pace L, Prastaro M, et al. Assessment of myocardial viability in patients with chronic coronary artery disease. Rest-4-hour-24- hour 201Tl tomography versus dobutamine echocardiography. Circulation. 1996;94:2712-2719.
13. Gutman J, Berman DS, Freeman M, et al. Time to completed redistribution of thallium-201 in exercise myocardial scintigraphy: relationship to the degree of coronary artery stenosis. Am Heart J. 1983;106:989-995.
14. Lin LC, Ho YL, Wu CC, et al. Comparison of simultaneous dobutamine echocardiography and thallium-201 stress-reinjection single-photon emission computed tomography in predicting improvement of chronic myocardial dysfunction after revascularization. Am J Cardiol. 2000;86:293-298.
15. Pace L, Perrone-filardi P, Mainenti P, et al. Combined evaluation of restredistribution thallium-201 tomography and low-dose dobutamine echocardiography enhances the identification of viable myocardium in patients with chronic coronary artery disease. Eur J Nucl Med. 1998;25:744-750.
16. Gunning MG, Anagnostopoulos C, Knight CJ, et al. Comparison of 201Tl, 99mTc-tetrofosmin, and dobutamine magnetic resonance imaging for identifying hibernating myocardium. Circulation. 1998;98:1869-1874.
17. Sicari R, Varga A, Picano E, et al. Comparison of combination of dipyridamole and dobutamine during echocardiography with thallium scintigraphy with thallium scintigraphy to improve viability detection. Am J Cardiol. 1999;83:6-10.
18. Bax JJ, Cornel JH, Visser FC, et al. Comparison of fluorine-18-FDG with rest-redistribution thallium-201 SPECT to delineate viable myocardium and predict functional recovery after revascularization. J Nucl Med. 1998;39: 1481-1486.